VERAXA Biotech Shows Regulatory Progress on Cancer Therapy Platform
By Daniella Parra VERAXA Biotech said it received positive scientific advice from Germany’s Paul-Ehrlich-Institute supporting a preclinical development plan for its experimental BiTAC-TCE cancer...
